ArticleJCO precision oncology2025

Physiologically Based Pharmacokinetic Model to Assess the Drug-Drug-Gene Interaction Potential of Belzutifan in Combination With Cyclin-Dependent Kinase 4/6 Inhibitors.

Darius Meiman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.